Export Market Readiness Checklist

United States · European Union · United Arab Emirates — cosmetics and aerosol product entry

Self-assessment worksheet. Tick each item that is fully in place and evidenced. Items marked CRITICAL are launch blockers — a market cannot be entered without them.

Read before use. This is a reference and planning aid, not regulatory advice and not a certification of compliance. It describes the structure of the requirements only; edition-specific quantity limits, thresholds, concentration limits and submission deadlines are deliberately excluded because they change. Verify every point against the current applicable legislation and, where the position is unclear, with a qualified regulatory professional in the destination market. Responsibility for any classification, declaration or submission remains with the shipper's own regulatory or QA function. Content last reviewed: 3 August 2026 · Check for a newer version before relying on this document.

Assessed by Date Reference

United States

European Union

UAE

Cross-cutting

Facility & entity obligations

✓	Requirement	What "in place" means
	Facility registration with FDA CRITICAL	Manufacturing site registered, registration number on record, renewal cycle diarised
	Product listing submitted per product CRITICAL	Each marketed cosmetic listed with ingredient detail; listing updated on reformulation
	Responsible Person identified for each product CRITICAL	The entity whose name appears on the label; contractual clarity on whether that is the brand owner or the manufacturer
	US agent / point of contact arrangement	Documented arrangement for FDA correspondence
	Small-business exemption position assessed	Determined whether exemptions apply; conclusion documented rather than assumed

Product safety & records

✓	Requirement	What "in place" means
	Safety substantiation on file per product CRITICAL	Adequate evidence of safety, held and retrievable; tests, literature and reasoning documented
	Adverse event reporting process CRITICAL	Intake route, assessment step, serious-event reporting timeline, and retention of records
	Talc-containing products testing position	Testing method and results where talc is used
	Intentionally added PFAS assessed	Supplier declarations obtained across the raw material base
	Good manufacturing practice readiness	Practices documented and gap-assessed against the expected framework

Labelling

✓	Requirement	What "in place" means
	Label carries Responsible Person contact for adverse events CRITICAL	Domestic address, phone or electronic contact as applicable
	Ingredient declaration in the required nomenclature and order	Reviewed against the US convention, not the EU one
	Fragrance allergen disclosure position tracked	Supplier allergen data available so the label can be updated when the rule applies
	Professional-use products labelled accordingly	Where relevant to the portfolio
	Claims reviewed against drug-claim boundary	A therapeutic claim reclassifies the product and changes the entire pathway

Entity & notification

✓	Requirement	What "in place" means
	Responsible Person established in the EU CRITICAL	A named EU-established legal entity with a written mandate; a non-EU manufacturer cannot hold this role itself
	CPNP notification completed before placing on the market CRITICAL	Notification reference retained; frame formulation and category correctly entered
	Poison centre / UFI arrangement where applicable	UFI generated and carried through to label and SDS as required
	Nanomaterial notification where applicable	Separate advance notification obligation with its own lead time

Product Information File

✓	Requirement	What "in place" means
	PIF compiled and held at the RP address CRITICAL	Accessible to authorities on request, in a language they accept
	Cosmetic Product Safety Report by a qualified assessor CRITICAL	Assessor qualification evidenced; report covers the specific formulation and packaging
	Manufacturing method statement with GMP reference	Alignment with the recognised cosmetics GMP standard, documented
	Stability and container-closure compatibility data	Supports the durability period and the packaging chosen
	Proof of claimed effects held	Evidence proportionate to the claim made
	No animal testing data relied upon CRITICAL	Position confirmed across the finished product and its ingredients

Composition & labelling

✓	Requirement	What "in place" means
	Formulation screened against prohibited and restricted lists CRITICAL	Annex screening repeated on each reformulation and on each regulation amendment
	Preservative, colourant and UV filter use within permitted entries	Concentration limits and conditions of use verified
	Fragrance allergen labelling applied	Declared where above the threshold for the product type
	Label content complete per the required particulars	RP address, nominal content, durability, precautions, batch code, function, INCI list
	Label translated for each destination member state	Language obligation is set nationally, not centrally

Registration & conformity

✓	Requirement	What "in place" means
	Product registration in the applicable national system CRITICAL	Registration certificate held, validity period and renewal date diarised
	Conformity certification maintained CRITICAL	Scope of the certificate covers the actual product categories being shipped
	Local importer / distributor relationship documented	Authorisation letters and responsibilities in writing
	Free sale certificate and legalisation route known	Issuing authority, attestation chain and lead time mapped
	Halal position determined where relevant	Applicable to certain categories and to specific customers

Product & labelling

✓	Requirement	What "in place" means
	Arabic labelling requirements met	Required particulars in Arabic, applied at the correct stage of packing
	Shelf life and production date marking as required	Format and placement per the national rule
	Ingredient restrictions screened against the applicable list	Regional restrictions do not always mirror the EU annexes
	Batch traceability to registration record	Shipped batch can be tied back to the registered product version

Systems that every market depends on

✓	Requirement	What "in place" means
	Single registration register across all markets CRITICAL	One authoritative record of which SKU is live in which market, under which client, with renewal dates. Spreadsheets held per person do not qualify.
	Renewal deadline alerting with escalation CRITICAL	Alerts at 90 / 30 / 7 days, escalating to a named owner; a missed renewal stops selling in that market
	Document version control for SDS, specs and certificates	Current version unambiguous; superseded versions retained but marked
	Change control that triggers regulatory re-review	A formulation, supplier or packaging change automatically raises the question of re-notification
	Regulatory change monitoring	Someone owns watching amendments, with a log of what changed and which SKUs are affected
	Training records tied to SOPs and roles CRITICAL	For any operator, current qualification against the current SOP version can be produced quickly
	Batch record retrieval within audit timescales	Any historical batch reconstructable without a manual search of physical files
	Complaint and recall procedure tested	Not merely written — exercised at least once, with the exercise recorded
	Client-facing document access	Brand clients can obtain COA, SDS and certificates without an email request each time
	Supplier qualification records current	Raw material and component suppliers assessed, with evidence on file

Why this tab usually scores lowest. Market-specific requirements tend to be handled well, because each has a visible deadline and an owner. The cross-cutting items have no external deadline until an audit or a missed renewal creates one — which is exactly why they are the items that fail.

Open items across all tabs

Nothing ticked yet — open items will be listed here as you work through the tabs.

Export Market Readiness Checklist — US / EU / UAE · Version 1.0 · Content last reviewed 3 August 2026
Prepared by hloo.in · servpga@gmail.com · Latest version: hloo.in/tools
Reference aid only — not regulatory advice. Verify against current legislation before use.

Prepared by hloo.in · servpga@gmail.com

Independent regulatory documentation & systems consulting

Version 1.0 · Latest version always at hloo.in/tools
Free to use, print and share internally. Please do not resell or remove attribution.